Giles, Abigail V.
Covian, Raul
Prag, Hiran A. https://orcid.org/0000-0002-4753-8567
Burger, Nils
Lucotte, Bertrand https://orcid.org/0000-0002-1646-1384
Yu, Chak Shun https://orcid.org/0009-0004-3106-9681
Sun, Junhui
Murphy, Elizabeth
Krieg, Thomas https://orcid.org/0000-0002-5192-580X
Murphy, Michael P. https://orcid.org/0000-0003-1115-9618
Balaban, Robert S. https://orcid.org/0000-0003-4086-0948
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_00028/4)
Wellcome Trust (220257/Z/20/Z)
British Heart Foundation (PG/23/11344)
U.S. Department of Health & Human Services | DHHS Office of the Secretary (ZIA HL004601-35)
Article History
Received: 17 December 2024
Accepted: 28 October 2025
First Online: 11 December 2025
Competing interests
: T.K. and M.P.M. are founders and officers of Camoxis Pharmaceuticals. The other authors declare no competing interests.